These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 3534695

  • 21. Schistosoma mansoni: surface membrane stability in vitro and in vivo.
    Ruppel A, McLaren DJ.
    Exp Parasitol; 1986 Oct; 62(2):223-36. PubMed ID: 3527740
    [Abstract] [Full Text] [Related]

  • 22. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages.
    James SL.
    J Immunol; 1986 May 15; 136(10):3872-7. PubMed ID: 3084646
    [Abstract] [Full Text] [Related]

  • 23. Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni.
    Ahmed SF, Oswald IP, Caspar P, Hieny S, Keefer L, Sher A, James SL.
    Infect Immun; 1997 Jan 15; 65(1):219-26. PubMed ID: 8975915
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Tumour necrosis factor (TNF) as a mediator of macrophage helminthotoxic activity.
    James SL, Glaven J, Goldenberg S, Meltzer MS, Pearce E.
    Parasite Immunol; 1990 Jan 15; 12(1):1-13. PubMed ID: 2314921
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.
    Pearce EJ, James SL, Hieny S, Lanar DE, Sher A.
    Proc Natl Acad Sci U S A; 1988 Aug 15; 85(15):5678-82. PubMed ID: 3135553
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antibody response against schistosomulum surface antigens and protective immunity following immunization with highly irradiated cercariae of Schistosoma mansoni.
    Simpson AJ, Hackett F, Walker T, de Rossi R, Smithers SR.
    Parasite Immunol; 1985 Mar 15; 7(2):133-52. PubMed ID: 4000699
    [Abstract] [Full Text] [Related]

  • 31. Schistosoma mansoni: liver phase challenge attrition is a stage-dependent phenomenon in guinea-pigs vaccinated with highly irradiated cercariae.
    McLaren DJ, Rogers MV.
    Parasite Immunol; 1986 Jul 15; 8(4):307-18. PubMed ID: 3092166
    [Abstract] [Full Text] [Related]

  • 32. Schistosoma mansoni: immunoblot analysis of adult worm proteins.
    Ruppel A, Rother U, Vongerichten H, Lucius R, Diesfeld HJ.
    Exp Parasitol; 1985 Oct 15; 60(2):195-206. PubMed ID: 3896836
    [Abstract] [Full Text] [Related]

  • 33. Screening of murine monoclonal antibodies against living schistosomula of Schistosoma mansoni by radioimmunoassay.
    Wiest PM, Wisnewski AV, Johnson JH, Ramirez B, Kresina TF, Olds GR.
    Int J Parasitol; 1991 Jul 15; 21(4):449-54. PubMed ID: 1917285
    [Abstract] [Full Text] [Related]

  • 34. Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine.
    Pearce EJ, James SL, Dalton J, Barrall A, Ramos C, Strand M, Sher A.
    J Immunol; 1986 Dec 01; 137(11):3593-600. PubMed ID: 2431037
    [Abstract] [Full Text] [Related]

  • 35. Lung-phase immunity to Schistosoma mansoni: definition of alveolar macrophage phenotypes after vaccination and challenge of mice.
    Menson EN, Wilson RA.
    Parasite Immunol; 1990 Jul 01; 12(4):353-66. PubMed ID: 2119492
    [Abstract] [Full Text] [Related]

  • 36. Comparison of immune responses between high and low responder strains of mice in the concomitant immunity and vaccine models of resistance to Schistosoma mansoni.
    James SL, Cheever AW.
    Parasitology; 1985 Oct 01; 91 ( Pt 2)():301-15. PubMed ID: 3934632
    [Abstract] [Full Text] [Related]

  • 37. Complement regulation on the surface of cultured schistosomula and adult worms of Schistosoma mansoni.
    Marikovsky M, Parizade M, Arnon R, Fishelson Z.
    Eur J Immunol; 1990 Jan 01; 20(1):221-7. PubMed ID: 2307175
    [Abstract] [Full Text] [Related]

  • 38. Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.
    El-Faham MH, Eissa MM, Igetei JE, Amer EI, Liddell S, El-Azzouni MZ, Doenhoff MJ.
    PLoS Negl Trop Dis; 2017 Aug 01; 11(8):e0005853. PubMed ID: 28841653
    [Abstract] [Full Text] [Related]

  • 39. Protective monoclonal antibodies from mice vaccinated or chronically infected with Schistosoma mansoni that recognize the same antigens.
    Gregoire RJ, Shi MH, Rekosh DM, Loverde PT.
    J Immunol; 1987 Dec 01; 139(11):3792-801. PubMed ID: 2445819
    [Abstract] [Full Text] [Related]

  • 40. Role of arginase in killing of schistosomula of Schistosoma mansoni.
    Olds GR, Ellner JJ, Kearse LA, Kazura JW, Mahmoud AA.
    J Exp Med; 1980 Jun 01; 151(6):1557-62. PubMed ID: 7381366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.